ClearNote Health is thrilled to announce that it has secured In Vitro Diagnostic approval in the UK for its revolutionary Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test-marking a powerful breakthrough in the battle for early cancer detection
4Moving Biotech has secured a €7.6 million grant from France 2030 to advance its innovative, first-in-class disease-modifying drug for osteoarthritis. This funding will support the company’s efforts to transform treatment options for this widespread condition.
bioMérieux has announced that it has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This diagnostic tool aims to enhance rapid testing for respiratory infections, providing efficient solutions for patient care in Canada.
